Affiliation:
1. Department of Oncology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO 63108, USA
Abstract
Human epidermal growth factor receptor 2 (HER2), a targetable transmembrane glycoprotein receptor of the epidermal growth factor receptor (EGFR) family, plays a crucial role in cell proliferation, survival, and differentiation. Aberrant HER2 signaling is implicated in various cancers, particularly in breast and gastric cancers, where HER2 overexpression or amplification correlates with aggressive tumor behavior and poor prognosis. HER2-activating mutations contribute to accelerated tumorigenesis and metastasis. This review provides an overview of HER2 biology, signaling pathways, mechanisms of dysregulation, and diagnostic approaches, as well as therapeutic strategies targeting HER2 in cancer. Understanding the intricate details of HER2 regulation is essential for developing effective targeted therapies and improving patient outcomes.
Reference101 articles.
1. Trenker, R., Diwanji, D., Bingham, T., Verba, K.A., and Jura, N. (2023). Structural Dynamics of the Active HER4 and HER2/HER4 Complexes Is Finely Tuned by Different Growth Factors and Glycosylation, Cold Spring Harbor Laboratory.
2. Structure and dynamics of the EGFR/HER2 heterodimer;Bai;Cell Discov.,2023
3. A central role for HER3 in HER2-amplified breast cancer: Implications for targeted therapy;Crocker;Cancer Res.,2008
4. Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas;Tang;OncoTargets Ther.,2014
5. Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers;Tsutsumi;Lung Cancer,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献